This federal contract award, valued at $1,007.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and an ultimate completion date of February 19, 2025. The contract covers the procurement of 4567304287 units of Methylergonovine 0.2 mg/ml, a medication used to treat certain postpartum conditions. AmerisourceBergen holds a larger...
This federal contract award, valued at $6,895.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of methylergonovine 0.2 mg/ml, a medication used to treat postpartum hemorrhage. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of methylergonovine 0.2 mg/ml vials, a medication used to treat postpartum hemorrhage. The contract has a ceiling value of $1,261.51 and runs through March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylergonovine 0.2 mg tablets, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price of $1,208.02 and a period of performance through April 11, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug...
This federal contract award, valued at $1,196.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566281359 - Methylergonovine 0.2 mg/ml VLML, a medication used in the treatment of various medical conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 31, 2024....
This federal contract award, valued at $2,393.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567064635 - Methylergonovine 0.2 mg/ml vials, with a final completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,196.66, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is a Delivery Order (DO) for the supply of 4566548161 - Methylergonovine 0.2 mg/mL, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price and a period of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,563,239,903 units of the drug Methylergonovine 0.2 mg Tablet. The contract has a ceiling value of $2,226.26 and a period of performance through January 5, 2024. It is a Firm Fixed Price Delivery Order contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $6,322.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of 4,563,416,314 units of the drug Methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of January 24, 2024 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,347.93 firm fixed-price delivery order is for the supply of 4565150115 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...